332 related articles for article (PubMed ID: 24376746)
1. Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2.
Cardani R; Bugiardini E; Renna LV; Rossi G; Colombo G; Valaperta R; Novelli G; Botta A; Meola G
PLoS One; 2013; 8(12):e83777. PubMed ID: 24376746
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.
Botta A; Vallo L; Rinaldi F; Bonifazi E; Amati F; Biancolella M; Gambardella S; Mancinelli E; Angelini C; Meola G; Novelli G
Gene Expr; 2007; 13(6):339-51. PubMed ID: 17708420
[TBL] [Abstract][Full Text] [Related]
3. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.
Ward AJ; Rimer M; Killian JM; Dowling JJ; Cooper TA
Hum Mol Genet; 2010 Sep; 19(18):3614-22. PubMed ID: 20603324
[TBL] [Abstract][Full Text] [Related]
4. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.
Tang ZZ; Yarotskyy V; Wei L; Sobczak K; Nakamori M; Eichinger K; Moxley RT; Dirksen RT; Thornton CA
Hum Mol Genet; 2012 Mar; 21(6):1312-24. PubMed ID: 22140091
[TBL] [Abstract][Full Text] [Related]
5. Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2.
Vihola A; Sirito M; Bachinski LL; Raheem O; Screen M; Suominen T; Krahe R; Udd B
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):390-405. PubMed ID: 22758909
[TBL] [Abstract][Full Text] [Related]
6. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes.
Santoro M; Piacentini R; Masciullo M; Bianchi ML; Modoni A; Podda MV; Ricci E; Silvestri G; Grassi C
Neuropathol Appl Neurobiol; 2014 Jun; 40(4):464-76. PubMed ID: 23888875
[TBL] [Abstract][Full Text] [Related]
8. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
9. Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2.
Cardani R; Giagnacovo M; Rossi G; Renna LV; Bugiardini E; Pizzamiglio C; Botta A; Meola G
Neuromuscul Disord; 2014 Dec; 24(12):1042-53. PubMed ID: 25139674
[TBL] [Abstract][Full Text] [Related]
10. Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice.
Wang M; Weng WC; Stock L; Lindquist D; Martinez A; Gourdon G; Timchenko N; Snape M; Timchenko L
Mol Cell Biol; 2019 Nov; 39(21):. PubMed ID: 31383751
[TBL] [Abstract][Full Text] [Related]
11. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.
Kimura T; Nakamori M; Lueck JD; Pouliquin P; Aoike F; Fujimura H; Dirksen RT; Takahashi MP; Dulhunty AF; Sakoda S
Hum Mol Genet; 2005 Aug; 14(15):2189-200. PubMed ID: 15972723
[TBL] [Abstract][Full Text] [Related]
12. (CCUG)
Yenigun VB; Sirito M; Amcheslavky A; Czernuszewicz T; Colonques-Bellmunt J; García-Alcover I; Wojciechowska M; Bolduc C; Chen Z; López Castel A; Krahe R; Bergmann A
Dis Model Mech; 2017 Aug; 10(8):993-1003. PubMed ID: 28623239
[TBL] [Abstract][Full Text] [Related]
13. Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.
Neault N; Ravel-Chapuis A; Baird SD; Lunde JA; Poirier M; Staykov E; Plaza-Diaz J; Medina G; Abadía-Molina F; Jasmin BJ; MacKenzie AE
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835205
[TBL] [Abstract][Full Text] [Related]
14. Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.
Bachinski LL; Baggerly KA; Neubauer VL; Nixon TJ; Raheem O; Sirito M; Unruh AK; Zhang J; Nagarajan L; Timchenko LT; Bassez G; Eymard B; Gamez J; Ashizawa T; Mendell JR; Udd B; Krahe R
Neuromuscul Disord; 2014 Mar; 24(3):227-40. PubMed ID: 24332166
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
Timchenko L
Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
[TBL] [Abstract][Full Text] [Related]
16. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
[TBL] [Abstract][Full Text] [Related]
17. PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1.
Wang GS; Kuyumcu-Martinez MN; Sarma S; Mathur N; Wehrens XH; Cooper TA
J Clin Invest; 2009 Dec; 119(12):3797-806. PubMed ID: 19907076
[TBL] [Abstract][Full Text] [Related]
18. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.
Cardani R; Baldassa S; Botta A; Rinaldi F; Novelli G; Mancinelli E; Meola G
Neuromuscul Disord; 2009 May; 19(5):335-43. PubMed ID: 19345584
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
20. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
Kim EY; Barefield DY; Vo AH; Gacita AM; Schuster EJ; Wyatt EJ; Davis JL; Dong B; Sun C; Page P; Dellefave-Castillo L; Demonbreun A; Zhang HF; McNally EM
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
